Startup Funding News

Explore funding rounds, the companies behind them and the investors taking part.

Rounds
4,758
Jan 1 – Oct 26, 2026
Disclosed funding
$346.8B
3695 disclosed amounts
Median round
$14.5M
Of disclosed amounts
4,758 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
Scholar EducationEdtech · United StatesCompany profile

Scholar Education builds AI tools for special-education teams and students, covering evaluation, classroom accommodations and progress monitoring.

Scholar Education builds AI tools for special-education teams and students, covering evaluation, classroom accommodations and progress monitoring.

$2MSeedEdtechUnited StatesInvestors
AIONA, Inc.Industrial tech · JapanCompany profile

AI design agents that help manufacturing engineers apply technical documents and past design knowledge across product-development workflows.

AI design agents that help manufacturing engineers apply technical documents and past design knowledge across product-development workflows.

¥140MJ-KISS and loan financingUndisclosedIndustrial techJapanInvestors
AndoEnterprise software · United StatesCompany profile

Ando provides team messaging where people and AI agents share conversations and working context.

Ando provides team messaging where people and AI agents share conversations and working context.

$20MCombined pre-seed and seedUndisclosedEnterprise softwareUnited StatesInvestors
50skillsEnterprise software · IcelandCompany profile

Employee and candidate workflows connecting HR systems, automation and human review.

Employee and candidate workflows connecting HR systems, automation and human review.

$6MFunding roundUndisclosedEnterprise softwareIcelandInvestors
QambriaEnterprise software · SwitzerlandCompany profile

Qambria builds software that connects quantum processors to high-performance computing systems, helping developers run hybrid quantum-classical workloads with low-latency control.

Qambria builds software that connects quantum processors to high-performance computing systems, helping developers run hybrid quantum-classical workloads with low-latency control.

CHF 850KInnosuisse grantUndisclosedEnterprise softwareSwitzerlandInvestors
Kasvu TherapeuticsBiotech · FinlandCompany profile

Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.

Kasvu Therapeutics develops small-molecule treatments intended to stimulate neuroplasticity without the hallucinogenic effects associated with psychedelic drugs.

€30MSeries ABiotechFinlandInvestors
Reply NextAI · SpainCompany profile

Reply Next helps multi-location brands manage reviews, ratings, customer messages and local search presence across digital platforms from one workspace.

Reply Next helps multi-location brands manage reviews, ratings, customer messages and local search presence across digital platforms from one workspace.

€400KPre-seedAISpainInvestors
ClastixDeveloper tools · ItalyCompany profile

Clastix builds Kubernetes infrastructure software, including Kamaji for hosted tenant control planes and kMetal for bare-metal cluster operations.

Clastix builds Kubernetes infrastructure software, including Kamaji for hosted tenant control planes and kMetal for bare-metal cluster operations.

€2.9MSeedDeveloper toolsItalyInvestors
Aligned Modern HealthHealthtech · United StatesCompany profile

A physician-led care provider offering functional medicine, hormone health and related services through clinics and telehealth.

A physician-led care provider offering functional medicine, hormone health and related services through clinics and telehealth.

UndisclosedMajority growth investmentGrowthHealthtechUnited StatesInvestors
United ImmunityBiotech · JapanCompany profile

A biotechnology company developing nanoparticle delivery systems and immunotherapies that target macrophages and dendritic cells in diseased tissue.

A biotechnology company developing nanoparticle delivery systems and immunotherapies that target macrophages and dendritic cells in diseased tissue.

¥2.2BPrivate financingUndisclosedBiotechJapanInvestors